Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FS47Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,508
Award facts
- Contract value 100% obligated
- $7,507.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $7,507.56 delivery order to Amerisourcebergen Drug Corp on July 13, 2026, for Rexulti 0.5 mg tablets (30-count), firm fixed-price, with ultimate completion July 14, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier serving federal healthcare and Defense health systems.
Quick answers
Who was awarded contract SPE2DR26FS47Y?
SPE2DR26FS47Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26FS47Y worth?
The government has obligated $7,508 on SPE2DR26FS47Y.
Is contract SPE2DR26FS47Y an order under another contract?
Yes. SPE2DR26FS47Y is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS47Y competed?
The extent of competition for SPE2DR26FS47Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award